Yervoy, known generically as ipilimumab, is a monoclonal antibody used in the treatment of various types of cancer. It was first approved by the FDA in 2011 for the treatment of melanoma, a serious form of skin cancer. Yervoy is classified as an immune checkpoint inhibitor, which means it works by enhancing the body's immune response against cancer cells.
